摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Isocyanato-1-phenyl-propan | 65535-55-9

中文名称
——
中文别名
——
英文名称
2-Isocyanato-1-phenyl-propan
英文别名
(2-isocyanato-propyl)-benzene;1-methyl-2-phenyl-ethyl isocyanate;1-Methyl-2-phenyl-aethylisocyanat;(2-Isocyanatopropyl)benzene;2-isocyanatopropylbenzene
2-Isocyanato-1-phenyl-propan化学式
CAS
65535-55-9
化学式
C10H11NO
mdl
MFCD11612971
分子量
161.203
InChiKey
JWGFMJHWOOMGMK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    29.4
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    2-Isocyanato-1-phenyl-propan 以76%的产率得到
    参考文献:
    名称:
    ARYA V. P.; DAVID J.; GREWAL R. S., INDIAN J. CHEM. , 1977, B 15, NO 7, 635-640
    摘要:
    DOI:
  • 作为产物:
    描述:
    alkaline earth salt of/the/ methylsulfuric acid 在 作用下, 生成 2-Isocyanato-1-phenyl-propan
    参考文献:
    名称:
    Jones; Wallis, Journal of the American Chemical Society, 1926, vol. 48, p. 180
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • [EN] ASSOCIATION OF ANTIMICROBIAL COMPOUNDS WITH SURFACES AND POLYMERS<br/>[FR] ASSOCIATION DE COMPOSES ANTIMICROBIENS A DES SURFACES ET DES POLYMERES
    申请人:BIOSIGNAL LTD
    公开号:WO2005053684A1
    公开(公告)日:2005-06-16
    The invention describes antimicrobial silicone oligomers or polymers comprising a silicone oligomer or polymer associated with at least one compound of formula (I). Also described are methods of associating compounds of formula (I) to surfaces and products thereof.
    该发明描述了含有硅氧烷寡聚物或聚合物的抗菌硅氧烷寡聚物或聚合物,该硅氧烷寡聚物或聚合物与至少一个化合物(I)相关联。还描述了将化合物(I)与表面相关联的方法及其产品。
  • Urea and thiourea compounds and compositions for cholesterol management and related uses
    申请人:Dasseux Henri Jean-Louis
    公开号:US20050192347A1
    公开(公告)日:2005-09-01
    The present invention relates to novel urea and thiourea compounds, compositions comprising urea or thiourea compounds, and methods useful for treating and preventing aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, enhancing bile production, enhancing reverse lipid transport, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, modulating C reactive protein, obesity, oxysterol elimination in bile, pancreatitis, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), a thrombotic disorder, gastrointestinal disease, irritable bowel syndrome (IBS), inflammatory bowel disease (e.g., Crohn's Disease, ulcerative colitis), arthritis (e.g., rheumatoid arthritis, osteoarthritis), autoimmune disease (e.g., systemic lupus erythematosus), scleroderma, ankylosing spondylitis, gout and pseudogout, muscle pain: polymyositis/polymyalgia rheumatica/fibrositis; infection and arthritis, juvenile rheumatoid arthritis, tendonitis, bursitis and other soft tissue rheumatism. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
    本发明涉及新型尿素硫脲化合物,包含尿素硫脲化合物的组合物,以及用于治疗和预防衰老、阿尔茨海默病、癌症、心血管疾病、糖尿病肾病、糖尿病视网膜病变、葡萄糖代谢紊乱、血脂异常、脂蛋白异常、增强胆汁产生、增强逆向脂质转运、高血压、阳痿、炎症、胰岛素抵抗、胆汁中脂质的清除、调节C反应蛋白、肥胖、胆汁中氧固醇的清除、胰腺炎、帕森病、过氧化物酶体增殖激活受体相关的疾病、胆汁中磷脂的清除、肾脏疾病、败血症、代谢综合征疾病(如X综合症)、血栓性疾病、胃肠道疾病、肠易激综合症(IBS)、炎症性肠病(如克罗恩病、溃疡性结肠炎)、关节炎(如类风湿性关节炎、骨关节炎)、自身免疫疾病(如系统性红斑狼疮)、硬皮病、强直性脊柱炎、痛风和假性痛风、肌肉疼痛:多发性肌炎/多发性肌痛症/纤维炎;感染和关节炎、儿童类风湿性关节炎、肌腱炎、滑囊炎和其他软组织风湿病的方法。在某些实施方式中,本发明的化合物、组合物和方法可与其他治疗药物(如降胆固醇和降血糖药物)联合治疗。
  • Direct synthesis by cationic polymerization of nitrogen-containing polymers
    申请人:EXXON CHEMICAL PATENTS INC.
    公开号:EP0349195A2
    公开(公告)日:1990-01-03
    A method is provided for the direct synthesis of novel polymeric materials functionalized with desirable nitrogen-containing functional groups such as terminal azido, cuano, carbonylamino or thiocarbonylamino groups. Polymerization and functionalization occur in a substantially simultaneous manner. All necessary reactants for the functionalization are present when polymerization is initiated. The nitrogen-containing functional group is provided as a part of a molecule having a release moiety which is preferably resonance stabilized or of tertiary alkyl type and which acts to aid the nitrogen-containing species in functioning as a leaving group.
    本发明提供了一种直接合成新型聚合物材料的方法,该材料具有理想的含氮官能团,如末端叠氮基、基、羰基基或代羰基基。聚合和官能化基本上是同时进行的。聚合开始时,官能化所需的所有反应物都已存在。含氮官能团是作为分子的一部分提供的,该分子具有释放基,释放基最好是共振稳定的或叔烷基类型的,其作用是帮助含氮物质作为离去基团发挥作用。
  • DENTAL PHOTOPOLYMERIZABLE COMPOSITION FOR 3D PRINTER
    申请人:Shofu Inc.
    公开号:EP3795359A1
    公开(公告)日:2021-03-24
    To provide a dental photopolymerizable composition which can prepare a dental restoration with excellent aesthetic and mechanical properties by optical three-dimensional modeling method (stereolithography). The dental photopolymerizable composition for 3D printer of the present invention comprises: a (a) (meth)acrylate-based polymerizable monomer consisting of a (a1) (meth)acrylate-based polymerizable monomer containing a urethane structure and a (a2) (meth)acrylate-based polymerizable monomer not containing a urethane structure, a (b) cohesive inorganic filler, and a (c) photopolymerization initiator, wherein; a ratio of the (a1) (meth)acrylate-based polymerizable monomer containing a urethane structure and the (a2) (meth)acrylate-based polymerizable monomer not containing a urethane structure in the (a) (meth)acrylate-based polymerizable monomer is 51:80 to 49:20 pts.wt., a ratio of the (a) (meth)acrylate-based polymerizable monomer and the (b) cohesive inorganic filler is 50:91 to 50:9 pts.wt., and the dental photopolymerizable composition for 3D printer contains 0.1 to 5 pts.wt. of the (c) photopolymerization initiator based on 100 pts.wt. of the (a) (meth)acrylate-based polymerizable monomer.
    提供一种牙科光可聚合组合物,该组合物可通过光学三维建模方法(立体光刻)制备出具有优异美学和机械性能的牙科修复体。本发明的 3D 打印机用牙科光聚合组合物包括由含有氨基甲酸酯结构的(a1)(甲基)丙烯酸酯基可聚合单体和不含氨基甲酸酯结构的(a2)(甲基)丙烯酸酯基可聚合单体组成的(a)(甲基)丙烯酸酯基可聚合单体、(b)内聚性无机填料和(c)光聚合引发剂,其中;含有氨基甲酸酯结构的(a1)(甲基)丙烯酸酯基可聚合单体与不含有氨基甲酸酯结构的(a2)(甲基)丙烯酸酯基可聚合单体在(a)(甲基)丙烯酸酯基可聚合单体中的比例为 51:重量比为 51:80 至 49:20。重量比(a)(甲基)丙烯酸酯基可聚合单体与(b)内聚性无机填料的比例为 50:91 至 50:9 个百分点重量比,且用于 3D 打印机的牙科光聚合组合物含有 0.1 至 5 个百分点重量比的(c)光聚合引发剂(基于 100 个百分点重量比的(a)(甲基)丙烯酸酯基可聚合单体)。
  • Enic compounds, sulfur-containing polyenic compound, sulfur-containing polythiol compound, high refractive index photocurable composition and cured product thereof
    申请人:——
    公开号:US20030195270A1
    公开(公告)日:2003-10-16
    A composition containing 3,3′-thiobis(propane-1,2-dithiol) and one or more enic compounds which composition is photocurable and can give a cured product having a high refractive index and adequate hardness.
    一种含有 3,3′-代双(丙烷-1,2-二醇)和一种或多种烯酸化合物的组合物,该组合物具有光固化性,可制成具有高折射率和足够硬度的固化产品。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫